Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 65 clinical trials
Featured trial
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Welcome to TogetherA study for memory loss If you are concerned about changes to your memory, joining the Together clinical study might be a suitable option for you. To qualify for this study, you must:·         Be between 50 and 80 years old·         Have mild memory problems or early Alzheimer’s disease·         Meet some additional study criteria The …

amyloid
cognitive impairment
mini-mental state examination
cognitive assessment
dementia
  • 99 views
  • 22 Sep, 2022
  • 86 locations
Featured trial
Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia

Care Partner Assisted Intervention to Improve Oral Health for Individuals with Mild Dementia is a randomized control trial (RCT) based in New York City and North Carolina. The intervention

mild dementia
mini-mental state examination
cognitive assessment
  • 0 views
  • 09 Feb, 2023
  • 2 locations
Featured trial
  • 34 views
  • 08 Dec, 2020
  • 1 location
Featured trial
A PATIENT- AND INVESTIGATOR-BLIND, PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPENLABEL EXTENSION PERIOD

Bepranemab (UCB0107) is being developed with the aim of blocking or reducing the cell-to-cell spread of tau pathology in patients with tau-mediated diseases, such as AD. To date, single ascending doses of bepranemab (up to 120mg/kg) have been evaluated in healthy study participants in two Phase 1 studies and no …

  • 14 views
  • 24 Jun, 2022
  • 1 location
Featured trial
Mild Dementia/Alzheimer's Disease

Mild Dementia/Alzheimer's Disease

  • 474 views
  • 25 Mar, 2021
  • 1 location
Featured trial
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease

cholinesterase
mild dementia
donepezil
cholinesterase inhibitors
galantamine
  • 3 views
  • 22 Nov, 2021
  • 12 locations
Featured trial
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.

Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.

  • 104 views
  • 08 Dec, 2020
  • 1 location
Featured trial
​The MGH Interdisciplinary Brain Center (IBC) Game Pack: A Panel of Digital Games for Tracking Cognitive Functioning in Adults with Subjective Cognitive Complaints, Mild Cognitive Impairment, or Mild Dementia​

people with cognitive decline, mild dementia, and Alzheimer's Disease. We believe that by capturing data about a person’s daily performance on these games can help us better understand cognitive

mild dementia
dementia
cognitive decline
alzheimer's disease
  • 2 views
  • 08 Mar, 2023
  • 1 location
Featured trial
An AI-based Method to Assess and Monitor the Cognitive Functions of Persons with Dementia

This pilot study will be investigating the feasibility of developing an AI solution to assess and monitor the progression of mild Alzheimer's dementia through automated speech and dialogue

dementia
Accepts healthy volunteers
  • 20 views
  • 22 Aug, 2022
  • 1 location